Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

US Patent 10188639 · Granted Jan 29, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions2025
Method of treating melanocortin-4 receptor pathway-associated disorders2025
Solid forms of enantiopure deuterium-enriched bupropion and methods of use there2024
Peptide compositions2024
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and meth2024
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and meth2024
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and meth2024
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivat2023
Deuterium-enriched isoindolinonyl-azepanediones and related compounds and method2023
Deuterium-enriched isoindolinonyl-azepanediones and related compounds and method2023
Methods of synthesizing enantiopure deuterium-enriched pioglitazone2023
Method of treating melanocortin-4 receptor-associated disorders in heterozygous 2023